Immune Pharmaceuticals Inc. (IMNP) Set to Announce Earnings on Thursday
mmune Pharmaceuticals Inc. (NASDAQ:IMNP) is scheduled to post its quarterly earnings results on Thursday, November 10th. Analysts expect Immune Pharmaceuticals to post earnings of ($0.14) per share for the quarter.
Immune Pharmaceuticals (NASDAQ:IMNP) last released its quarterly earnings results on Tuesday, August 16th. The biopharmaceutical company reported ($0.13) earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of ($0.13). On average, analysts expect Immune Pharmaceuticals to post $-0.58 EPS for the current fiscal year and $-0.17 EPS for the next fiscal year.
Shares of Immune Pharmaceuticals Inc. (NASDAQ:IMNP) traded down 2.9950% during trading on Tuesday, reaching $0.1749. The company had a trading volume of 2,103,717 shares. The company’s 50 day moving average is $0.25 and its 200-day moving average is $0.35. Immune Pharmaceuticals Inc. has a 1-year low of $0.17 and a 1-year high of $1.54. The stock’s market capitalization is $13.85 million.
Separately, FBR & Co reaffirmed a “buy” rating on shares of Immune Pharmaceuticals in a report on Sunday, September 18th.
Immune Pharmaceuticals Company Profile
Immune Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The Company is engaged in the development and commercialization of targeted therapeutics in the fields of immuno-inflammation and immuno-oncology. The Company’s segment is acquiring, developing and commercializing prescription drug products.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.